Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
IBUPROFEN
Abbott Laboratories Ireland Ltd
100 MG/5ml
Oral Suspension
2001-03-02
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Brufen Paediatric 100 mg / 5 ml Oral Suspension. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 ml contains 100 mg ibuprofen Excipients: Each 5ml also contains: 5mg methyl parahydroxybenzoate (E218) 2.5mg propyl parahydroxybenzoate (E216) 500mg sorbitol solution non-crystallising (E420) 3.3g sucrose 0.5mg sunset yellow FC edicol (E110) For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension. Orange-coloured and flavoured syrup-like suspension. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Brufen Paediatric Oral Suspension is indicated in the management of various arthroses such as rheumatoid arthritis (including juvenile rheumatoid arthritis or Still’s Disease) and osteoarthritis, fibrositis, ankylosing and other muscular syndromes such as low back pain, soft tissue trauma and various inflammations of tendon, joint capsules and ligaments. As an analgesic in the relief of mild to moderate pain. For the treatment of pyrexia in children. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (_see section 4.4, Special warnings and precautions for use_). _Adults: _The recommended dosage of Brufen is 1200-1800 mg daily in divided doses. Some patients can be maintained on 600-1200 mg daily. Total daily dose should not exceed 2400 mg. _Children: _The recommended dose of Brufen is 20 mg per kg of bodyweight daily in divided doses. This can be achieved as follows: 1-2 years: 2.5 ml (50 mg) three to four times a day. 3-7 years: one 5 ml spoonful (100 mg) three to four times a day. 8-12 years: two 5 ml spoonfuls (200 mg) three to four times a Read the complete document